
Medtech Goes to Capitol Hill
AdvaMed’s annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our…
Learn more about our Digital Health work.
AdvaMed’s annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our…
Join King & Spalding in this session that will discuss how the FDA is shaping the use of AI in the life sciences sector, providing a roadmap for companies to…
This webinar will explore recent intellectual property cases, proposed legislation, and other key legal developments impacting the medical technology industry.
Join Accenture in this discussion about global tariff tensions and evolving FDA challenges—exacerbated by Department of Government Efficiency (DoGE) cost-cutting initiatives—are creating significant uncertainty for the MedTech industry.
In this cutting-edge webinar, discover how AI is accelerating advancements in precision medicine, automating complex processes and enabling early detection and treatment of diseases through data-driven insights.
Join Genpact for in this engaging session that will show you how to empower customer support agents with real-time and multilingual access to critical information, streamlined notetaking, and easier onboarding.
Join Salesforce for a webinar exploring how a connected life sciences platform with embedded AI can revolutionize commercial operations and field engagement to transform the future of engagement.
AdvaMed calls for federal privacy laws that reflect how medical devices use patient data differently from consumer health tools.
WASHINGTON—AdvaMed, the Medtech Association, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen…
Join Sunrise Labs in discussion of how in today’s climate of economic uncertainty, regulatory complexity, and constrained capital markets, securing investor funding is more challenging—and more vital—than ever for medtech…